United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at HMG New York Global Innovation Virtual Summit Transcript

Jun 26, 2020 / 05:35PM GMT
Release Date Price: €110 (+2.80%)
Hunter Muller
HMG Strategy, LLC - CEO and President

Next up, our panel on top technology innovators. Welcome, Dr. Daniel Durand. Daniel, welcome to the program.

Daniel, you're the Chief Innovation Officer of LifeBridge Health. Tell us -- give us an update. What are you seeing relative to the pandemic? And what's the way ahead, the road ahead?

Questions & Answers

Daniel Durand
LifeBridge Health, Inc. - VP & Chief Innovation Officer

Yes, there's a pretty broad runway in those questions. So when it comes to the pandemic, you'd have to really think about which geography you're talking about. Certainly, here in the United States, we had things under fairly good control about this time last week or so it seemed. Then we've had quite a resurgence, and it is differential by geography. Where I currently sit in Maryland, things are going fairly well, but that's not the case in all places.

I think that just kind of reminds us of what this is likely to continue to feel like. We noticed all of the technological trends associated with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot